EE200200551A - Pharmaceutical composition containing oligosaccharides, oligosaccharides, their preparation and therapeutic use - Google Patents

Pharmaceutical composition containing oligosaccharides, oligosaccharides, their preparation and therapeutic use

Info

Publication number
EE200200551A
EE200200551A EEP200200551A EEP200200551A EE200200551A EE 200200551 A EE200200551 A EE 200200551A EE P200200551 A EEP200200551 A EE P200200551A EE P200200551 A EEP200200551 A EE P200200551A EE 200200551 A EE200200551 A EE 200200551A
Authority
EE
Estonia
Prior art keywords
oligosaccharides
preparation
pharmaceutical composition
composition containing
therapeutic use
Prior art date
Application number
EEP200200551A
Other languages
Estonian (et)
Inventor
Mourier Pierre
Perrin Elisabeth
Viskov Christian
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of EE200200551A publication Critical patent/EE200200551A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
EEP200200551A 2000-03-28 2001-03-26 Pharmaceutical composition containing oligosaccharides, oligosaccharides, their preparation and therapeutic use EE200200551A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0003910A FR2807043B1 (en) 2000-03-28 2000-03-28 PHARMACEUTICAL COMPOSITION CONTAINING OLIGOSACCHARIDES, NEW OLIGOSACCHARIDES AND THEIR PREPARATION
PCT/FR2001/000903 WO2001072762A1 (en) 2000-03-28 2001-03-26 Pharmaceutical compositions containing oligosaccharides and preparation thereof

Publications (1)

Publication Number Publication Date
EE200200551A true EE200200551A (en) 2004-04-15

Family

ID=8848572

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200551A EE200200551A (en) 2000-03-28 2001-03-26 Pharmaceutical composition containing oligosaccharides, oligosaccharides, their preparation and therapeutic use

Country Status (27)

Country Link
EP (1) EP1272499B1 (en)
JP (1) JP2003529570A (en)
KR (1) KR20030001394A (en)
CN (1) CN1183149C (en)
AR (1) AR034251A1 (en)
AT (1) ATE290543T1 (en)
AU (1) AU782713B2 (en)
BR (1) BR0109617A (en)
CA (1) CA2403906A1 (en)
DE (1) DE60109279T2 (en)
EA (1) EA004768B1 (en)
EE (1) EE200200551A (en)
ES (1) ES2236206T3 (en)
FR (1) FR2807043B1 (en)
HK (1) HK1056564A1 (en)
HU (1) HUP0300330A3 (en)
IL (1) IL151832A0 (en)
ME (1) MEP88408A (en)
MX (1) MXPA02009455A (en)
NO (1) NO20024590L (en)
NZ (1) NZ521558A (en)
PL (1) PL204419B1 (en)
PT (1) PT1272499E (en)
SK (1) SK286745B6 (en)
WO (1) WO2001072762A1 (en)
YU (1) YU72802A (en)
ZA (1) ZA200207707B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750207B1 (en) * 1992-05-01 2004-06-15 Yeda Research And Development Co. Ltd. Compositions for the regulation of cytokine activity
FR2845686B1 (en) * 2002-10-10 2013-08-30 Aventis Pharma Sa MIXTURES OF HEPARIN-DERIVED POLYSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7511026B2 (en) * 2003-03-25 2009-03-31 Seikagaku Corporation Therapeutic agent for nerve damage
FR2857971B1 (en) * 2003-07-24 2005-08-26 Aventis Pharma Sa MIXTURES OF HEPARIN DERIVED OLIGOSACCHARIDES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US20050186679A1 (en) * 2004-02-24 2005-08-25 Christian Viskov Method for determining specific groups constituting heparins or low molecular weight heparins
JP5116071B2 (en) * 2005-07-20 2013-01-09 帝國製薬株式会社 Use of anti-neuropathic pain effects of D-allose and D-psicose
JP5137118B2 (en) 2005-08-30 2013-02-06 国立大学法人高知大学 Universal base
EP3418287A1 (en) * 2017-06-21 2018-12-26 Universität für Bodenkultur Wien Chemical release of asparaginelinked glycans
CN115317507A (en) * 2022-09-19 2022-11-11 中国科学院海洋研究所 Application of low molecular weight fucoidan in preparation of anti-hyperactivity drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449688A (en) * 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases

Also Published As

Publication number Publication date
CA2403906A1 (en) 2001-10-04
CN1183149C (en) 2005-01-05
PL357301A1 (en) 2004-07-26
JP2003529570A (en) 2003-10-07
ATE290543T1 (en) 2005-03-15
EP1272499B1 (en) 2005-03-09
AU4663901A (en) 2001-10-08
EA004768B1 (en) 2004-08-26
NZ521558A (en) 2005-10-28
PL204419B1 (en) 2010-01-29
HUP0300330A3 (en) 2003-09-29
HK1056564A1 (en) 2004-02-20
EA200201024A1 (en) 2003-02-27
PT1272499E (en) 2005-06-30
WO2001072762A1 (en) 2001-10-04
DE60109279D1 (en) 2005-04-14
BR0109617A (en) 2003-02-04
CN1426419A (en) 2003-06-25
IL151832A0 (en) 2003-04-10
MEP88408A (en) 2011-12-20
DE60109279T2 (en) 2006-04-13
MXPA02009455A (en) 2003-02-12
FR2807043A1 (en) 2001-10-05
FR2807043B1 (en) 2002-11-22
ZA200207707B (en) 2003-12-24
AU782713B2 (en) 2005-08-25
AR034251A1 (en) 2004-02-18
KR20030001394A (en) 2003-01-06
EP1272499A1 (en) 2003-01-08
NO20024590D0 (en) 2002-09-25
ES2236206T3 (en) 2005-07-16
SK286745B6 (en) 2009-04-06
SK13932002A3 (en) 2003-06-03
NO20024590L (en) 2002-09-25
HUP0300330A2 (en) 2003-06-28
YU72802A (en) 2006-01-16

Similar Documents

Publication Publication Date Title
EE200100684A (en) Indalyl-substituted benzenecarboxamides, process for their preparation, use and pharmaceutical compositions
EE200100391A (en) Peptidyl-heterocyclic ketones, their use and pharmaceutical composition
EE05475B1 (en) Superantigen Conjugate, Conjugate Use, and Conjugate Containing Pharmaceutical Composition
EE200300145A (en) Aza and polyazanaphthalenylcarboxamides and pharmaceutical composition
EE05104B1 (en) Azetidine derivatives, methods for their preparation and pharmaceutical composition
EE200300207A (en) Heterocyclylalkylpiperidine Derivatives, Methods of Preparation, and Pharmaceutical Composition
EE05183B1 (en) Azabitic compounds, their preparation and use as pharmaceuticals, and the pharmaceutical composition containing them
EE05081B1 (en) Pharmaceutical compositions containing 3-aminoacetidine derivatives, 3-aminoacetidine derivatives and methods for their preparation
EE05149B1 (en) Biar acarboxamides, process for their preparation, pharmaceutical composition containing them and their use in therapy
EE200100431A (en) 16-haloepothilone derivatives, process for their preparation and pharmaceutical use
HUP0400837A3 (en) 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them
HUP0204474A3 (en) 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use
EE05134B1 (en) Adamantane derivatives, a process for their preparation, pharmaceutical compositions containing them and their use in therapy
ATE355271T1 (en) PHARMACEUTICAL COMPOSITION
EE200300048A (en) Benzimidazole derivatives, their preparation and therapeutic use
EE04497B1 (en) Pyridopyranoazepine derivatives, their preparation and therapeutic use
EE04236B1 (en) Benzimidazoles, their preparation and use as medicaments
EE05000B1 (en) 2'-Substituted 1,1'-biphenyl-2-carboxamides, their use and pharmaceutical preparations
DE60037816D1 (en) PHARMACEUTICAL FORMULATION CONTAINING MEGALATRANE AND ITS PRO-PHARMAKA
EE200200342A (en) Substituted 8-arylquinolines, their use, pharmaceutical composition and precursor compound
EE04955B1 (en) Pharmaceutical preparation for oral or topical administration and pharmaceutical form
EE200000651A (en) Azoles, process for their preparation, use and pharmaceutical composition
ATE366128T1 (en) PHARMACEUTICAL COMPOSITION
BR0012184B1 (en) indole-derived compounds, pharmaceutical formulation, and composition and use of the compounds in the manufacture of medicaments
EE200200551A (en) Pharmaceutical composition containing oligosaccharides, oligosaccharides, their preparation and therapeutic use